In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer’s disease
- 348 Downloads
Progressive brain atrophy is believed to be the Alzheimer’s disease (AD) marker with the greatest evidence for validity. Mapping the topography of cortical atrophy throughout the stages of severity may allow the neural networks affected to be identified. Twenty healthy elderly persons (OH, MMSE 29.1 ± 1.0), 11 patients with incipient AD (iAD, 26.5 ± 2.0), 15 with mild AD (miAD, 23.5 ± 2.2), and 15 with moderate AD (moAD, 16.5 ± 2.0) underwent 3D magnetic resonance. Cortical pattern matching analysis was performed and maps of percent differences in gray matter distribution were computed between the following groups: iAD versus OH, miAD versus iAD, and moAD versus miAD. Compared to OH, iAD patients exhibited a mean cortical gray matter loss of 9–20% in areas encompassing the polysynaptic hippocampal pathway (posterior cingulate/retrosplenial and medial temporal cortex) and subgenual/orbitofrontal cortices, and a less widespread loss of 5–11% in other neocortical areas. Compared to iAD, miAD featured widespread mean gray matter loss of 14–19% in areas encompassing the direct hippocampal pathway (temporal pole, temporoparietal association cortex, and dorsal prefrontal cortex), sensorimotor, and visual cortex, with a less marked loss (7–9%) in the polysynaptic pathway areas. Compared to miAD, only atrophy in the primary sensorimotor cortex was still relatively marked in moAD, with a mean gray matter loss of 10–11%; the loss in other regions was generally below 10%. These findings suggest that the polysynaptic hippocampal pathway is affected in iAD, the direct pathway and sensorimotor and visual networks are affected in moAD, and the sensorimotor network is affected in moAD.
KeywordsAlzheimer’s disease Cortical pattern matching Brain atrophy Mild cognitive impairment (MCI) Volumetric MRI
We wish to thank Francesca Sabattoli for help in the inter-rater reliability of cortical pattern matching, and Michela Pievani for continuous technical and logistic support.
Conflict of interest statement
The authors report no conflicts of interest.
- 1.Committee for Medicinal Products for Human Use (CHMP) (2007) Guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias (draft; CPMP/EWP/553/95 Rev. 1). CHMP, LondonGoogle Scholar
- 7.Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 71:441–447PubMedCrossRefGoogle Scholar
- 10.Lezak M, Howieson D, Loring DW (2004) Neuropsychological assessment, 4th edn. University Press, OxfordGoogle Scholar
- 13.Riello R, Sabattoli F, Beltramello A, Bonetti M, Bono G, Falini A, Magnani G, Minonzio G, Piovan E, Alaimo G, Ettori M, Galluzzi S, Locatelli E, Noiszewska M, Testa C, Frisoni GB (2005) Brain volumes in healthy adults aged 40 years and over: a voxel-based morphometry study. Aging Clin Exp Res 17:329–336PubMedGoogle Scholar
- 14.Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW (2004) Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22(4):1754–1766; erratum (2007) 36:1397–1398Google Scholar
- 15.Heilbrun MP, Koehler S, MacDonald P, Siemionow V, Peters W (1994) Preliminary experience using an optimized three-point transformation algorithm for spatial registration of coordinate systems: a method of noninvasive localization using frame-based stereotactic guidance systems. J Neurosurg 81:676–682PubMedCrossRefGoogle Scholar
- 22.Duvernoy HM (1998) The human hippocampus: functional anatomy, vascularization and serial sections with MRI. Springer, New York, pp 29–30Google Scholar